Back to Search
FRANK VICINI, M.D.
M.D.
Radiation Oncology Physician
NPI: 1871553826IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
4301405983(MI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1985
Research & Publications (20)
Molecular evidence demonstrating local treatment failure is the source of distant metastases in some patients treated for breast cancer.
PMID 18410995·Int J Radiat Oncol Biol Phys·2008
8-other
Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
PMID 18181095·Cancer·2008
3-trial
Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
PMID 17967306·Int J Radiat Oncol Biol Phys·2007
8-other
The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
PMID 17372920·Cancer·2007
8-other
Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation.
PMID 17306933·Int J Radiat Oncol Biol Phys·2007
8-other
A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
PMID 16198508·Int J Radiat Oncol Biol Phys·2005
3-trial
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
PMID 16088962·Cancer·2005
3-trial
Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer.
PMID 15821460·J Urol·2005
6-review
Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
PMID 15465188·Int J Radiat Oncol Biol Phys·2004
8-other
Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy.
PMID 15337543·Int J Radiat Oncol Biol Phys·2004
8-other
Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
PMID 14630258·Int J Radiat Oncol Biol Phys·2003
3-trial
Limited-field radiation therapy in the management of early-stage breast cancer.
PMID 12928345·J Natl Cancer Inst·2003
8-other
High dose rate brachytherapy in the treatment of prostate cancer.
PMID 12905008·World J Urol·2003
6-review
The role of high-dose rate brachytherapy in locally advanced prostate cancer.
PMID 12728439·Semin Radiat Oncol·2003
6-review
Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?
PMID 12569590·Cancer·2003
8-other
Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy.
PMID 12459355·Int J Radiat Oncol Biol Phys·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 70 FULTON ST
PONTIAC, MI 48341 - Phone
- (248) 338-0300
Quick Facts
- NPI
- 1871553826
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile